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Aims: A substitution of diacylglycerol (DAG) oil for triacylglycerol (TAG) oil in diet has been 
reported to reduce body fat and body weight, possibly by increasing postprandial energy expen-
diture (EE). We have previously studied plasma serotonin, which increases EE and exists in the 
small intestine, in individuals who ingested TAG and DAG oil, and found that DAG ingestion 
elevates plasma serotonin levels by about 50% compared with TAG ingestion. We studied the 
molecular mechanisms for DAG-mediated increase in serotonin and EE.
Methods: We studied effects of 1-monoacylglycerol and 2-monoacylglycerol, distinct digestive 
products of DAG and TAG, respectively, on serotonin release from the Caco-2 cells (the human 
intestinal cell line, n = 8). Further, we studied effects of 1- and 2-monoacylglycerol, and sero-
tonin on expression of mRNA associated with β-oxidation, FA metabolism, and thermogenesis, 
in the Caco-2 cells (n = 5).
Results: 1-monoacylglycerol (100 µM 1-monooleyl glycerol [1-MOG]) significantly increased 
serotonin release from the Caco-2 cells compared with 2-monoacylglycerol (100 µM 2-MOG) 
by 36.6%. Expression of mRNA of acyl-CoA oxidase (ACO), fatty acid translocase (FAT), 
and uncoupling protein-2 (UCP-2) were significantly higher in 100 µM 1-MOG-treated Caco-2 
cells than 100 µM 2-MOG-treated cells by 12.8%, 23.7%, and 35.1%, respectively. Further, 
expression of mRNA of ACO, medium-chain acyl-CoA dehydrogenase, FAT, and UCP-2 were 
significantly elevated in serotonin (400 nM)-treated Caco-2 cells compared with cells incubated 
without serotonin by 28.7%, 30.1%, and 39.2%, respectively.
Conclusions: Our study demonstrated that 1-monoacylglycerol, a digestive product of DAG, 
increases serotonin release from the Caco-2 cells, and enhances expression of genes associated 
with β-oxidation, FA metabolism, and thermogenesis, and that serotonin increases expression 
of these genes, proposing a novel molecular mechanism for DAG-mediated promotion of 
negative caloric balance.
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Introduction
Diacylglycerol (DAG) is a natural component of various edible oils. DAG has been 
reported to be more effective for preventing excess adiposity through a variety of 
potential mechanisms in comparison with triacylglycerol (TAG) in humans.1 In a study 
that examined the effects of DAG-rich diet on postprandial energy expenditure (EE) and 
respiratory quotient (RQ), the amount of changed EE after DAG ingestion was higher 
than that after TAG ingestion, and RQ after DAG ingestion was significantly lower than 
that after TAG ingestion, suggesting that DAG increases EE by inducing higher 
lipid oxidation compared with TAG.2 We have previously studied plasma serotonin, Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010:3 
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which increases EE and body temperature, in subjects who 
ingested TAG and DAG.3 In that study, we found that DAG 
oil ingestion elevates plasma serotonin levels by about 50%, 
compared with TAG oil ingestion, suggesting a possible 
mechanism for postprandial increase in EE by DAG.
Dietary TAG oil is hydrolyzed by lipase to free fatty 
acids (FFA) and 2-monoacylglycerol in the intestinal 
lumen, and these metabolites are absorbed by intestinal 
cells.1 In the case of DAG oil, the metabolic pathway 
in the intestinal cells is different from that of TAG oil. 
1,3-DAG, the main form of DAG oil, would be hydrolyzed 
to 1-monoacylglycerol and FFA.1 To understand how DAG 
ingestion increases plasma serotonin levels as compared with 
TAG ingestion, we studied effects of 1-monoacylglycerol and 
2-monoacylglycerol, hydrolytic products of DAG and TAG, 
respectively, on serotonin release from the intestinal cells, the 
Caco-2 cells. Further, we studied effects of serotonin, 1- and 
2-monoacylglycerol on expression of mRNA of acyl-CoA 
oxidase (ACO), medium-chain acyl-CoA dehydrogenase 
(MCAD), fatty acid translocase (FAT), and uncoupling 
protein-2 (UCP-2), which are associated with β-oxidation, 
FA metabolism, and thermogenesis.
Materials and methods
cells
Caco-2 cells were obtained from ATCC (American Type 
Culture Collection, Manassas, VA). Caco-2 cells were 
grown in 75-cm2 plastic flasks at 37 °C in a 5% CO2 95% air 
environment. The culture medium consisted of Dulbecco’s 
modified Eagle’s medium (DMEM), 20% fetal bovine serum 
(FBS), 100 IU/ml penicillin, and 100 µg/ml streptomycin. 
Cells reached confluence after 4–5 days in culture.
effects of 1-monooleyl glycerol (1-MOg) 
and 2-MOg on serotonin release and 
expression of mRnA of AcO, McAD, 
FAT, and UcP-2 in the caco-2 cells
1-MOG and 2-MOG were purchased from Doosan Serdary 
Research Laboratories (Toronto, ON, Canada), and were 
dissolved and dispersed in 10 mmol/l taurocholate in 
phosphate-buffered saline (PBS), pH 7.4, to obtain the 
desired concentration, and were further incubated for 
one hour at 37 °C with shaking at 90 rpm to obtain a 
homogeneous solution. The stable monomer concentrations 
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Figure  effects of 1-monooleyl glycerol (1-MOg) and 2-monooleyl glycerol (2-MOg) on serotonin release from the caco-2 cells.
Notes: Boxes and bars indicate mean ± SD. n = 8. *P  0.001 versus 2-MOg-treated cells.Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010:3 
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for oleic acid and 2-monoacylglycerol have been reported 
to be 200 µM and 125 µM, respectively.4 The Caco-2 
cells were then incubated with medium containing 100 µM 
and 200 µM 1-MOG or 2-MOG at 37 °C for 24 hours, and 
serotonin concentrations in the medium were measured 
by a previously reported method.5 Briefly, serotonin was 
separated by high-performance liquid chromatography with 
column-switching system, and was specifically converted 
into a fluorescent derivative with benzylamine for convenient 
detection.5
Total RNA was extracted from the Caco-2 cells, and 
cDNA was synthesized using 1 µg of total RNA by reverse 
transcription after treatment with DNase. Quantitative 
polymerase chain reaction (PCR) was done using the 7500 
Real-Time PCR system and the TaqMan Gene Expression 
Assay system (Applied Biosystems, Foster City, CA). Gene 
expression analyses of ACO, MCAD, FAT, and UCP-2 were 
performed by relative quantitation (RQ) assay using 18S as 
an internal control. The Taqman Gene Expression Assays 
Hs01074241, Hs00936576, Hs01567186, Hs01075227, and 
Hs99999901_S1 were used for ACO, MCAD, FAT, UCP-2, 
and 18S, respectively.
effects of serotonin on expression 
of mRnA of AcO, McAD, FAT, 
and UcP-2
Caco-2 cells were incubated with medium without and with 
50 nM and 400 nM serotonin at 37 °C for 24 hours. Total 
RNA was extracted from the Caco-2 cells, and cDNA 
was synthesized using 1 µg of total RNA by reverse tran-
scription after treatment with DNase. Quantitative PCR 
was done using the 7500 Real-Time PCR system and the 
TaqMan Gene Expression Assay system (Applied Biosys-
tems). Gene expression analyses of ACO, MCAD, FAT, and 
UCP-2 were performed by Relative RQ assay using 18S as 
an internal control. The Taqman Gene Expression Assays 
Hs01074241, Hs00936576, Hs01567186, Hs01075227, and 
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Figure  effects of 100 µM 1-monooleyl glycerol (1-MOg) and 2-monooley glycerol (2-MOg) on expression of mRnA of acyl-coA oxidase (AcO) A) medium-chain acyl-coA 
dehydrogenase (McAD) B) fatty acid translocase (FAT) C) and uncoupling protein-2 (UcP-2) D) in the caco-2 cells.
Notes: Boxes and bars indicate mean ± SD of relative quantitation mRnA values using 18S as an internal control. n = 8. *P  0.001 versus 2-MOg-treated cells.Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010:3 
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Hs99999901_S1 were used for ACO, MCAD, FAT, UCP-2, 
and 18S, respectively.
Statistical analysis
Values were expressed as mean ± standard deviation (SD). 
Comparison of serotonin concentration in the medium of 
Caco-2 cells treated with 1-MOG and 2-MOG was analyzed 
using the Mann–Whitney U test. Comparison of mRNA 
expressions of ACO, MCAD, FAT, and UCP-2 in the Caco-2 
cells incubated with 1-MOG and 2-MOG was analyzed using 
the Mann–Whitney U test. Comparisons in mRNA expres-
sions of ACO, MCAD, FAT, and UCP-2 in the Caco-2 cells 
incubated with different concentrations of serotonin, were 
analyzed by one-factor analysis of variance (ANOVA) and 
Scheffe’s F test.
Results
100 µM 1-MOG significantly increased serotonin release 
from the Caco-2 cells compared with 100 µM 2-MOG 
by 36.6% (P  0.001, Mann–Whitney U test) (Figure 1). 
Although a statistical significant difference was not obtained, 
increased serotonin release was observed in the Caco-2 cells 
treated with 200 µM 1-MOG as compared with cells treated 
with 200 µM 2-MOG.
Expression of mRNA of ACO, FAT, and UCP-2 were 
significantly higher in 100 µM 1-MOG-treated Caco-2 cells 
than 100 µM 2-MOG-treated cells by 12.8% (P  0.01), 
23.7% (P  0.01), and 35.1% (P  0.01), respectively 
(Figure 2).
Further, expression of mRNA of ACO, MCAD, FAT, and 
UCP-2 were significantly elevated in serotonin (400 nM)-
treated Caco-2 cells compared with cells incubated without 
serotonin by 28.7% (P  0.01), 30.1% (P  0.01), and 39.2% 
(P  0.01), respectively.
Discussion
Upregulated mRNA expression associated with mitochon-
drial and peroxisomal β-oxidation and thermogenesis in 
the small intestine may explain in part mechanism for 
DAG-mediated increase in postprandial EE.6,7 The small 
intestine is likely to be the key organ to make differences 
in energy metabolism between DAG and TAG. Serotonin 
is present in great quantity in the small intestine, and is 
associated with increase in oxygen consumption and body 
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Figure  effects of serotonin on expression of mRnA of acyl-coA oxidase (AcO) A) medium-chain acyl-coA dehydrogenase (McAD) B) fatty acid translocase (FAT) C) and 
uncoupling protein-2 (UcP-2) D) in the caco-2 cells.
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temperature.8,9 An administration of a serotonin receptor 
agonist significantly increased body temperature and EE in 
Zucker rats in a dose-dependent manner, and a selective sero-
tonin receptor antagonist completely inhibited this increase 
in EE, suggesting that serotonin regulates thermogenesis and 
EE.10 A single injection of serotonin in rats stimulated rest-
ing oxygen consumption; this was reduced by pretreatment 
with automatic nerve ganglion blocking agent, indicating that 
serotonin mediates peripheral sympathetic thermogenesis.11 
We have previously studied plasma serotonin in subjects who 
ingested TAG and DAG, and found that DAG oil ingestion 
elevates plasma serotonin levels by about 50% compared 
with TAG oil ingestion, suggesting a possible mechanism 
for postprandial increase in EE by DAG.3
To reveal further molecular mechanisms underlying this 
effect of DAG, we performed this study. We demonstrated 
that 1-MOG, a digestive product of DAG, significantly 
increased serotonin release, and also enhanced expression of 
mRNA of ACO, FAT, and UCP-2, compared with 2-MOG, 
a digestive product of TAG, in the Caco-2 cells. Further, our 
study showed that serotonin upregulates expression of mRNA 
associated with β-oxidation, FA metabolism, and thermogen-
esis. These results suggest that a digestive product of DAG 
increases serotonin release, and serotonin induces expression 
of genes associated with elevation in energy expenditure, 
and consequently leading to DAG-mediated promotion of 
negative caloric balance. To our knowledge, the present 
study is the first to report serotonin-mediated elevation in 
expression of genes associated with β-oxidation, FA metabo-
lism, and thermogenesis. However, it remains unclear how 
much 1- or 2-monoacylglycerol exists in the intestine when 
we ingested DAG or TAG oil. Therefore, we exactly don’t 
know whether or not the concentrations used in our studies 
are similar to those expected in a natural biological system 
or simply artificial. To make our preliminary results valid 
and meaningful, we should investigate the concentration of 
metabolites in the intestine after TAG or DAG oil ingestion, 
and should also study a dose-dependent and a time-dependent 
effect of serotonin and 1-, 2-monoacylglycerol for expres-
sion of genes associated with β-oxidation, FA metabolism, 
and thermogenesis.
More than 90% of total body content of serotonin is 
synthesized, stored and released by intestinal enterochro-
maffin cells. Activation of the various receptors such as 
cholinergic, nicotinic, and serotonin 3 receptors, trigger 
intracellular messenger systems, which regulate the secretion 
of serotonin.12 Monoacylglycerol has been reported to act as 
an endogenous ligand for the cannabinoid receptors,13 which 
seem to be involved in serotonin 3 receptors.14 Although 
we should perform more studies to elucidate the underlying 
mechanism in the future, 1-monoacylglycerol may be more 
strongly associated with stimulatory receptors for serotonin 
release from the enterochromaffin cells compared with 
2-monoacylglycerol.
Serotonin has been reported to be associated with 
vasoconstriction and platelet function.15 In our previous study,3 
we studied plasma von-Willebrand factor, thrombomodulin, 
and p-selection in individuals who ingested TAG and DAG, 
and did not observe a significant difference between TAG 
and DAG ingestion (data not shown). A significance of  DAG-
mediated increase in plasma serotonin for atherosclerosis 
remains unclear, which should be elucidated.
In conclusion, our study demonstrated that a hydro-
lytic product of DAG increases serotonin release from the 
Caco-2 cells, and enhances expression of genes associated 
with β-oxidation, thermogenesis, and FA metabolism, 
which were also upregulated by serotonin, proposing a new 
molecular biological mechanism for DAG-induced promo-
tion of negative caloric balance.
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